n-methylglycinamide has been researched along with carmustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feindel, W; Panasci, LC; Skalski, V | 2 |
| Marcantonio, D; Noë, AJ; Panasci, LC | 1 |
3 other study(ies) available for n-methylglycinamide and carmustine
| Article | Year |
|---|---|
Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cells.
Topics: Biological Transport, Active; Carmustine; Glioma; Glycine; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Sarcosine; Sodium; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
Topics: Antineoplastic Agents; Biological Transport; Brain Neoplasms; Carmustine; Cell Line; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Sarcosine; Tritium; Tumor Cells, Cultured | 1989 |
SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity.
Topics: Biological Transport; Carmustine; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Catecholamines; Humans; Membrane Transport Proteins; Sarcosine; Tumor Cells, Cultured | 1996 |